Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.57
Delayed Data
As of Apr 24
 +0.04 / +0.88%
Today’s Change
3.92
Today|||52-Week Range
8.38
-1.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$593.5M

Company Description

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA.

Contact Information

Keryx Biopharmaceuticals, Inc.
12th Floor
Boston Massachusetts 02210
P:(617) 466-3500
Investor Relations:
(617) 466-3511

Employees

Shareholders

Other institutional43.50%
Mutual fund holders22.34%
Individual stakeholders13.54%

Top Executives

Gregory P. MadisonPresident, Chief Executive Officer & Director
Christine A. CarberryChief Operating Officer & Senior Vice President
Scott A. HolmesChief Financial Officer & Senior Vice President
John F. NeylanChief Medical Officer & Senior Vice President
Melissa Bradford-KlugChief Business Officer & Senior Vice President